We have a PROVEN track record of our portfolio companies completing liquidity events through IPOs and merger and acquisition transactions.
BioVex develops cancer therapies utilizing an oncolytic virus technology that replicates and spreads within solid tumors, causing the death of cancer cells, while leaving surrounding healthy cells unharmed.
Crystal IS develops UV light-emitting diodes (LEDs) for air and water purification and industrial processes.
Innovalight develops processes to manufacture high-efficiency silicon photovoltaic (solar) cells based on proprietary silicon-nanocrystal inks.
NanoGram Devices used a patented laser pyrolysis-based synthesis process known as Nano-Particle Manufacturing and a deposition variant of this technology known as Laser Reactive Deposition to make nanoscale lithium/silver vanadium oxide.
NeoPhotonics designs and manufactures photonic integrated circuit (PIC) modules and subsystems for high-speed communications networks.
NeuroMetrix uses low-level, non-invasively measured, electrophysiological signals from nerves and muscles to perform an array of clinical diagnostic tests.
Solazyme, Inc., transforms low-cost plant sugars into tailored, high-value renewable oils.
Copyright © 2012 Harris & Harris Group. All rights reserved.